Skip to main content
logo
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
148.21
+12.01 (8.82%)
At close: Jun 26, 2026, 4:00 PM EDT
148.49
+0.28 (0.19%)
Pre-market: Jun 29, 2026, 4:31 AM EDT

Palvella Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '16
Net Income
-49.3-41.72-17.4318.69-33.28-22.8
Depreciation & Amortization
----2.780.36
Stock-Based Compensation
8.686.40.830.64.41.91
Other Adjustments
8.356.495.96-29.85-0.470.05
Change in Receivables
0.392.49-1.98--2.62-0.06
Changes in Accounts Payable
2.111.262.24-2.25-4.211.36
Changes in Accrued Expenses
-2.2-1.31.05-1.18-4.012.06
Changes in Unearned Revenue
-----20.193.75
Changes in Other Operating Activities
0.961.36-1.50.27-2.35-1.02
Operating Cash Flow
-29.1-25.01-10.84-13.7-59.93-14.39
Capital Expenditures
-----1.04-0.58
Sale of Property, Plant & Equipment
-----0.02
Purchases of Investments
-55.44----48.4-
Proceeds from Sale of Investments
----28.2-
Investing Cash Flow
-55.44----21.24-0.56
Long-Term Debt Issued
--18.43---
Net Long-Term Debt Issued (Repaid)
--18.43---
Issuance of Common Stock
231.650.76--7.21-
Net Common Stock Issued (Repurchased)
231.650.76--7.21-
Other Financing Activities
-17.49-1.4268.665-15.22
Financing Cash Flow
215.27-0.6687.0957.2115.22
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.040.050--5.18-0.27
Net Cash Flow
130.77-25.6276.25-8.7-79.136.4
Free Cash Flow
-29.1-25.01-10.84-13.7-60.97-14.97
Free Cash Flow Per Share
-2.48-2.22-4.87-7.64-33.99-28.71
Levered Free Cash Flow
-19.95-40.392.7814.77-62.28-16.86
Unlevered Free Cash Flow
-44.72-37.28-12.31-15.02-98.38-22.49
SEC Filings: 10-K · 10-Q